Filings
Finds words inside filing documents. Searching CERO THERAPEUTICS HOLDINGS, INC.'s filings · 47 documents indexed.
7 documents · 38 matches
-
CERO CERO THERAPEUTICS HOLDINGS, INC. 10-K 2026-04-15
Item 1A. Risk Factors.
material weaknesses in our system of internal financial and accounting controls and procedures, as defined in the SEC guidelines for public9 matches in this document -
CERO CERO THERAPEUTICS HOLDINGS, INC. 10-Q 2025-11-19
Item 1A. Risk Factors
material weaknesses in our system of internal financial and accounting controls and procedures, as defined in the SEC guidelines for public8 matches in this document -
CERO CERO THERAPEUTICS HOLDINGS, INC. 10-Q 2025-08-22
Item 1A. Risk Factors
material weaknesses in our system of internal financial and accounting controls and procedures, as defined in the SEC guidelines for public8 matches in this document -
CERO CERO THERAPEUTICS HOLDINGS, INC. 10-Q 2025-05-15
Item 4. Controls and Procedures
material weakness led to the Company consistently failing to meet contractual deadlines for filing its financial statements. In order to remediate2 matches in this document -
CERO CERO THERAPEUTICS HOLDINGS, INC. 10-Q 2026-08-14
Item 4. Controls and Procedures
disclosure controls and procedures were not effective due to the existence of material weaknesses in internal control over financial reporting.5 matches in this document -
CERO CERO THERAPEUTICS HOLDINGS, INC. 10-Q 2026-05-15
Item 4. Controls and Procedures
disclosure controls and procedures were not effective due to the existence of material weaknesses in internal control over financial reporting.5 matches in this document -
CERO CERO THERAPEUTICS HOLDINGS, INC. 8-K 2026-02-13
Item 4.01. Changes in Registrant’s Certifying Accountant.
material weakness in internal control over financial reporting related to the Company’s conclusion that due to a lack of sufficient1 match in this document
Page 1 of 1 · 7 documents